. 2022 Nov 21;33(11):e13885. doi: 10.1111/pai.13885
© 2022 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
FIGURE 1.
Study design ICS, inhaled corticosteroid; SABA, short‐acting β2‐agonist.